Renee Foekens
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer.
Journal: Cancer discovery
Published: February 02, 2024
HER2-low breast cancer shows a lower immune response compared to HER2-negative cases.
Journal: Scientific reports
Published: April 08, 2022
The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer.
Journal: BMC cancer
Published: November 24, 2021
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer.
Journal: Nature communications
Published: June 02, 2020
The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to Outcome.
Journal: Cancers
Published: April 09, 2018
Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.
Journal: International journal of cancer
Published: November 03, 2017
Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 30, 2017
Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients.
Journal: Scientific reports
Published: February 09, 2016
SIAH2 protein expression in breast cancer is inversely related with ER status and outcome to tamoxifen therapy.
Journal: American journal of cancer research
Published: November 06, 2015
Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response.
Journal: Molecular & cellular proteomics : MCP
Published: April 19, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026